Literature DB >> 11485827

tetra-O-methylnordihydroguaiaretic acid inhibits melanoma in vivo.

J D Lambert1, R O Meyers, B N Timmermann, R T Dorr.   

Abstract

tetra-O-methylnordihydroguaiaretic acid is a derivative of a naturally-occurring lignan, nordihydroguaiaretic acid, that has previously been shown to inhibit various cancer types in vitro and in vivo. Additionally, nordihydroguaiaretic acid has been shown to have nephrotoxic effects in the rat. Here we show that tetra-O-methylnordihydroguaiaretic acid inhibits the growth of a number of tumor cell lines in vitro by inducing apoptosis in a non-schedule-dependent manner. Further, this compound inhibits the synthesis of DNA by melanoma cells and causes cell cycle arrest in G0/G1 and G2/M phases of the cell cycle. tetra-O-Methylnordihydroguaiaretic acid also inhibits the growth of both murine and human melanomas and human colon cancer in vivo without apparent hepatic or renal toxicity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11485827     DOI: 10.1016/s0304-3835(01)00560-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  Synthesis of 2,3-disubstituted benzo[b]furans by the palladium-catalyzed coupling of o-iodoanisoles and terminal alkynes, followed by electrophilic cyclization.

Authors:  Dawei Yue; Tuanli Yao; Richard C Larock
Journal:  J Org Chem       Date:  2005-12-09       Impact factor: 4.354

2.  Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells.

Authors:  Angel Mauricio Castro-Gamero; Kleiton Silva Borges; Daniel Antunes Moreno; Veridiana Kill Suazo; Mayara Missono Fujinami; Rosane de Paula Gomes Queiroz; Harley Francisco de Oliveira; Carlos Gilberto Carlotti; Carlos Alberto Scrideli; Luiz Gonzaga Tone
Journal:  Invest New Drugs       Date:  2013-01-09       Impact factor: 3.850

3.  Phase I study of terameprocol in patients with recurrent high-grade glioma.

Authors:  Stuart A Grossman; Xiaobu Ye; David Peereboom; Myrna R Rosenfeld; Tom Mikkelsen; Jeffrey G Supko; Serena Desideri
Journal:  Neuro Oncol       Date:  2012-02-08       Impact factor: 12.300

4.  Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression.

Authors:  Chih-Chuan Chang; Jonathan D Heller; Jennifer Kuo; Ru Chih C Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

5.  Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid.

Authors:  Ross O Meyers; Joshua D Lambert; Nicole Hajicek; Alan Pourpak; John A Kalaitzis; Robert T Dorr
Journal:  Bioorg Med Chem Lett       Date:  2009-06-21       Impact factor: 2.823

6.  A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors.

Authors:  Jian-hong Chen; Xiao-hong Yao; Wanghua Gong; Jinyue Hu; Xiang-dong Zhou; Keqiang Chen; Hong Liu; Yi-fang Ping; Ji Ming Wang; Xiu-wu Bian
Journal:  J Neurooncol       Date:  2007-03-22       Impact factor: 4.506

7.  Benzofuranyl Esters: Synthesis, Crystal Structure Determination, Antimicrobial and Antioxidant Activities.

Authors:  C S Chidan Kumar; Li Yee Then; Tze Shyang Chia; Siddegowda Chandraju; Yip-Foo Win; Shaida Fariza Sulaiman; Nurul Shafiqah Hashim; Kheng Leong Ooi; Ching Kheng Quah; Hoong-Kun Fun
Journal:  Molecules       Date:  2015-09-11       Impact factor: 4.411

8.  Synthesis of 3-selanylbenzo[b]furans promoted by SelectFluor®.

Authors:  Maurício Carpe Diem Ferreira Xavier; Eduardo Martarelo Andia Sandagorda; José Sebastião Santos Neto; Ricardo Frederico Schumacher; Márcio Santos Silva
Journal:  RSC Adv       Date:  2020-04-07       Impact factor: 4.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.